Curis INC Form 4 insider transactions

Jonathan B. Zung, Chief Development Officer of Curis Inc., reports the acquisition of 15,000 shares through an employee stock option grant.

Director Kenneth Kaitin reported the acquisition of stock options in Curis Inc. on January 28, 2025.

Director Marc Rubin reported the acquisition of 1,600 non-qualified stock options in Curis Inc. on January 28, 2025.

Director Anne Elizabeth Borgman acquired 1,600 non-qualified stock options in Curis Inc., vesting on January 28, 2026.

Director John Hohneker acquired 1,600 non-qualified stock options in Curis Inc. on January 28, 2025.

Director Martyn D Greenacre reports the acquisition of stock options in Curis Inc.

Diantha Duvall, CFO of Curis Inc., reports the grant of a stock option for 39,000 shares following shareholder approval of the Fifth Amended and Restated 2010 Stock Incentive Plan.

Curis Inc. CEO James E. Dentzer was granted a stock option to purchase 100,000 shares of common stock after shareholders approved the Fifth Amended and Restated 2010 Stock Incentive Plan.

Jonathan B. Zung, Chief Development Officer of Curis Inc., was granted 40,700 employee stock options at an exercise price of $11.62 following shareholder approval of the company's Fifth Amended and Restated 2010 Stock Incentive Plan.

Director Kenneth Kaitin reports the acquisition of 4,250 non-qualified stock options in Curis Inc. after shareholder approval of the Fifth Amended and Restated 2010 Stock Incentive Plan.

Director Marc Rubin reports the acquisition of stock options in Curis Inc. following shareholder approval of the company's Fifth Amended and Restated 2010 Stock Incentive Plan.

Director Anne Elizabeth Borgman reports the acquisition of stock options in Curis Inc. following shareholder approval of the company's Fifth Amended and Restated 2010 Stock Incentive Plan.

Director John Hohneker received a stock option grant for 4,250 shares of Curis Inc. following shareholder approval of the Fifth Amended and Restated 2010 Stock Incentive Plan.

Director Martyn D Greenacre received a stock option grant for 4,250 shares of Curis Inc. following shareholder approval of the company's Fifth Amended and Restated 2010 Stock Incentive Plan.